The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Cidara Therapeutics, Inc(NASDAQ:CDTX) 
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel long-acting anti-infectives for the treatment and prevention of diseases in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the...
Website: http://www.cidara.com
Founded: 2012
Full Time Employees: 68
Sector: Healthcare
Industry: Biotechnology
Cidara Therapeutics Days Payable Outstanding ttm (DPO)
Cidara Therapeutics Days Receivable Outstanding ttm (DSO)
Cidara Therapeutics Days Inventory Outstanding ttm (DIO)
Cidara Therapeutics Op Cashflow Per Share ttm
Cidara Therapeutics Free Cashflow Per Share ttm
Cidara Therapeutics Cash Per Share ttm
Cidara Therapeutics P/S ratio ttm
Cidara Therapeutics (GAAP) P/E ratio ttm
Cidara Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.